This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lonza Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Thomas Ellis - Innovator in Biologics Production
Introduction
Thomas Ellis is a notable inventor based in Stratham, NH (US). He has made significant contributions to the field of biologics production through his innovative patent. His work focuses on enhancing the efficiency and control of bioreactor systems, which are crucial in the production of biologics.
Latest Patents
Thomas Ellis holds a patent titled "System and method for regulating cell culture based production of biologics." This patent describes a comprehensive system and method for controlling at least one bioreactor and other related equipment. The system includes a Plant-Wide Control System (PWCS) or a Process Control System (PCS) that is divided into three main components: hardware, software, and instrument control loops. These components work together to maintain specific process values, ensuring optimal production conditions.
Career Highlights
Throughout his career, Thomas has demonstrated a commitment to advancing biotechnological processes. His innovative approach has led to the development of systems that improve the regulation of cell culture-based production, which is essential for the manufacturing of biologics. His expertise in this area has positioned him as a valuable contributor to the field.
Collaborations
Thomas Ellis has collaborated with notable colleagues, including Rex Polley and Matthew Sarcopski. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Thomas Ellis is a distinguished inventor whose work in regulating cell culture-based production of biologics has made a significant impact in the field. His patent and collaborative efforts continue to influence advancements in biotechnological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
